首页> 外国专利> NON-GLYCOSYLATED/NON-GLYCOSIDIC/NON-PEPTIDIC SMALL MOLECULE PSGL-1 MIMETICS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

NON-GLYCOSYLATED/NON-GLYCOSIDIC/NON-PEPTIDIC SMALL MOLECULE PSGL-1 MIMETICS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

机译:非糖基化/非糖苷/非肽类小分子PSGL-1模拟物治疗炎症性疾病

摘要

Pharmaceutical compositions comprising at least one compound of the formulas (Ia) or (Ib) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols, indices and substituents have the following meaning R1H, CN, NO2, CF3, F, Cl, Br, I, CH3 R2H, CN, NO2, CF3, F, Cl, Br, I, CH3, Et, n-Pr, i-Pr, n-Bu, t-Bu, phenyl, thienyl, furyl, thiazolyl and either R1 or R2 must be H R3H, CN, NO2, CF3, F, Cl, Br, I, CH3, Et, n-Pr, i-Pr, n-Bu, t-Bu, phenyl, thienyl, furyl, thiazolyl then X is e.g. with R4 being H, CH3, CH2CH3 or and Y being or the pharmaceutically acceptable salts, esters or amides and prodrugs of the above identified compounds of formulas (Ia) or (Ib). The compounds are applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or L-selectin binding.
机译:包含至少一种式(Ia)或(Ib)化合物和可药用载体的药物组合物,其在药物中有用,其中符号,索引和取代基具有以下含义:R 1 H,CN,NO 2,CF 3,F,Cl ,Br,I,CH3 R2H,CN,NO2,CF3,F,Cl,Br,I,CH3,Et,n-Pr,i-Pr,n-Bu,t-Bu,苯基,噻吩基,呋喃基,噻唑基和R1或R2必须为H R3H,CN,NO2,CF3,F,Cl,Br,I,CH3,Et,n-Pr,i-Pr,n-Bu,t-Bu,苯基,噻吩基,呋喃基,噻唑基那么X是例如R 4为H,CH 3,CH 2 CH 3或,且Y为上述鉴定的式(Ia)或(Ib)化合物的药学上可接受的盐,酯或酰胺和前药。将该化合物应用于调节由E-,P-或L-选择蛋白结合介导的体外和体内结合过程。

著录项

  • 公开/公告号EP1732882A1

    专利类型

  • 公开/公告日2006-12-20

    原文格式PDF

  • 申请/专利权人 REVOTAR BIOPHARMACEUTICALS AG;

    申请/专利号EP20050716209

  • 发明设计人 KRANICH REMO;AYDT EWALD MIRKO;

    申请日2005-03-18

  • 分类号C07C233;C07C237;

  • 国家 EP

  • 入库时间 2022-08-21 20:50:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号